ALLISON MCGEE: Open Payments
NPI 1467950659 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,575 in 86 payments from 24 companies in 2025. Trend: 2023 $356 · 2024 $485 · 2025 $1,575
Food & beverage: $1,575
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $174 |
| AstraZeneca Pharmaceuticals LP | 4 | $171 |
| Amgen Inc. | 12 | $161 |
| ABBVIE INC. | 11 | $150 |
| PFIZER INC. | 9 | $144 |
| Kite Pharma, Inc. | 1 | $104 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Exact Sciences Corporation | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
Products named: BREZTRI, Yescarta, REPATHA, REXULTI, EVENITY, NURTEC ODT, UBRELVY, Rybelsus.
Industry payments across ID — which companies pay providers there.
